Stock Comparison

BMRN vs VRTX

Biomarin Pharmaceutical Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BMRN

Biomarin Pharmaceutical Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$12.29B

$123.94B

P/E (TTM)

171.6

28.5

Forward P/E

12.8

25.7

Price/Sales

3.6

9.9

Price/Book

1.9

6.1

EV/EBITDA

40.6

23.2

Dividend Yield

—

Profitability

Net Margin

8.29%

35.40%

Operating Margin

13.55%

38.97%

Return on Equity

1.18%

23.50%

Return on Assets

3.26%

11.90%

Growth (YoY)

Revenue Growth

19.90%

12.50%

Earnings Growth

-81.30%

8.00%

Price & Risk

Beta

0.2

0.3

52-Week High

$70.24

$529.65

52-Week Low

$49.67

$376.62

Analyst Target

$88.16

$559.28

Compare BMRN and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.